Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

ClinicalTrials.gov ID: NCT00559962

Public ClinicalTrials.gov record NCT00559962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 4:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Low Doses of the MTP-Inhibitor AEGR-733 on Hepatic Fat Accumulation as Measured by Magnetic Resonance Spectroscopy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine safety and effectiveness of low-dose therapeutic AEGR-733 +/- atorvastatin, ezetimibe or fenofibrate (compared to placebo) on liver fat accumulation measured by Magnetic Resonance Spectroscopy

Study identification

NCT ID
NCT00559962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aegerion Pharmaceuticals, Inc.
Industry
Enrollment
260 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2007 (Type not available)
Primary completion
Oct 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Feb 23, 2018

2007 – 2008

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Scripps Clinic San Diego California 92128 —
Radiant Research Santa Rosa California 95405 —
MedStar Research Institute Washington D.C. District of Columbia 20003 —
Radiant Research Chicago Illinois 60610 —
University of Iowa Iowa City Iowa 52242 —
LMARC Louisville Kentucky 40213 —
Maine Research Associates Auburn Maine 04210 —
Health Trends Research Baltimore Maryland 21209 —
Johns Hopkins Baltimore Maryland 21287 —
Washington Univ. School of Medicine St Louis Missouri 63110 —
Sterling Research Group Cincinnati Ohio 45219 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Baylor College of Medicine Houston Texas 77030 —
Clinical Trial Network Houston Texas 77074 —
dgd Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00559962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2018 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00559962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →